118 related articles for article (PubMed ID: 2175221)
21. Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium.
Chan AK; Patel S; Male C; Berry LR; Mitchell LG
Thromb Haemost; 2004 Feb; 91(2):238-47. PubMed ID: 14961149
[TBL] [Abstract][Full Text] [Related]
22. Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever.
Vicente V; España F; Tabernero D; Estellés A; Aznar J; Hendl S; Griffin JH
Blood; 1991 Jul; 78(2):416-22. PubMed ID: 1648982
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of activated protein C in guinea pigs.
Berger H; Kirstein CG; Orthner CL
Blood; 1991 May; 77(10):2174-84. PubMed ID: 2029578
[TBL] [Abstract][Full Text] [Related]
24. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
España F; Estelles A; Griffin JH; Aznar J
Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
[TBL] [Abstract][Full Text] [Related]
25. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
Shen L; Dahlbäck B; Villoutreix BO
Biochemistry; 2000 Mar; 39(11):2853-60. PubMed ID: 10715104
[TBL] [Abstract][Full Text] [Related]
26. In vivo catabolism of alpha 1-antichymotrypsin is mediated by the Serpin receptor which binds alpha 1-proteinase inhibitor, antithrombin III and heparin cofactor II.
Pizzo SV; Mast AE; Feldman SR; Salvesen G
Biochim Biophys Acta; 1988 Nov; 967(2):158-62. PubMed ID: 3263884
[TBL] [Abstract][Full Text] [Related]
27. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
[TBL] [Abstract][Full Text] [Related]
28. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
Watanabe R; Wada H; Sakakura M; Mori Y; Nakasaki T; Okugawa Y; Gabazza EC; Hayashi T; Nishioka J; Suzuki K; Shiku H; Nobori T
Am J Hematol; 2000 Sep; 65(1):35-40. PubMed ID: 10936861
[TBL] [Abstract][Full Text] [Related]
29. Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor.
Kuhn LA; Griffin JH; Fisher CL; Greengard JS; Bouma BN; España F; Tainer JA
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8506-10. PubMed ID: 2172989
[TBL] [Abstract][Full Text] [Related]
30. Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein.
Laurell M; Stenflo J
Thromb Haemost; 1989 Nov; 62(3):885-91. PubMed ID: 2556811
[TBL] [Abstract][Full Text] [Related]
31. A qualitative and quantitative analysis of the activation and inactivation of protein C in vivo in a primate model.
Hoogendoorn H; Nesheim ME; Giles AR
Blood; 1990 Jun; 75(11):2164-71. PubMed ID: 2346780
[TBL] [Abstract][Full Text] [Related]
32. Protein C and its inhibitor in malignancy.
Suzuki K; Hayashi T
Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of human activated protein C. 1st communication: plasma concentration and excretion of a lyophilized purified human activated protein C after intravenous administration in the mouse and the rabbit.
Ishii S; Mochizuki T; Nagao T; Sugiki S; Kudo S; Harakawa N; Taniguchi K; Igarashi Y; Kondo S; Kiyoki M
Arzneimittelforschung; 1995 May; 45(5):636-44. PubMed ID: 7612068
[TBL] [Abstract][Full Text] [Related]
34. Inhibition and complexation of activated protein C by two major inhibitors in plasma.
Heeb MJ; España F; Griffin JH
Blood; 1989 Feb; 73(2):446-54. PubMed ID: 2917184
[TBL] [Abstract][Full Text] [Related]
35. A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitor.
Strandberg K; Kjellberg M; Knebel R; Lilja H; Stenflo J
Thromb Haemost; 2001 Aug; 86(2):604-10. PubMed ID: 11522010
[TBL] [Abstract][Full Text] [Related]
36. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
Meijers JC; Kanters DH; Vlooswijk RA; van Erp HE; Hessing M; Bouma BN
Biochemistry; 1988 Jun; 27(12):4231-7. PubMed ID: 2844223
[TBL] [Abstract][Full Text] [Related]
38. Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: relationship with systemic inflammation and haemostatic activation.
Mezzano D; España F; Panes O; Medina P; Pais E; Marshall G; Tagle R; Downey P; Caceres S; González F; Quiroga T; Pereira J
Br J Haematol; 2001 Jun; 113(4):905-10. PubMed ID: 11442482
[TBL] [Abstract][Full Text] [Related]
39. Activation of the protein C system during cardiopulmonary bypass with and without aprotinin.
Speekenbrink RG; Bertina RM; España F; Wildevuur CR; Eijsman L
Ann Thorac Surg; 1998 Dec; 66(6):1998-2002. PubMed ID: 9930483
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.
Ecke S; Geiger M; Resch I; Jerabek I; Sting L; Maier M; Binder BR
J Biol Chem; 1992 Apr; 267(10):7048-52. PubMed ID: 1313031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
